DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Intravenous Immunoglobulins Market 2017-2021" report to their offering.
The global intravenous immunoglobulins market to grow at a CAGR of 7.62% during the period 2017-2021.
The report, Global Intravenous Immunoglobulins Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend in the market is monetary support to plasma donors. The intravenous immunoglobulin market is growing at steady rate, where the number of plasma donors affects the overall supply chain. Therefore, to maintain and meet the demands of plasma-derived therapeutics, a plasma donor receives monetary compensation.
According to the report, one driver in the market is growing number of fractionating units. Fractionation is a crucial step in the manufacture of immunoglobulins. This step involves separation of immunoglobulins and other blood protein from plasma. The capacity of fractionating units is increasing. Data estimates suggest that during 2013-2016, the capacity increased by 39.5%. This increased capacity is primarily due to the installment of new fractionating units or expansion of existing fractionating units.
- CSL Behring
Other prominent vendors
- ADMA Biologics
- Bharat Serum and Vaccines
- Biotest AG
- China Biologic Products
- Hualan Biological Engineering
- Kedrion Biopharma
- LFB Group
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: An overview of diseases treated using intravenous immunoglobulins
PART 06: Market landscape
PART 07: Pipeline landscape
PART 08: Market segmentation by Therapy area
PART 09: Geographical segmentation
PART 10: Decision framework
PART 11: Drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
For more information about this report visit https://www.researchandmarkets.com/research/jvzz96/global